ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

PHC Plant Health Care Plc

3.73
0.00 (0.00%)
Last Updated: 08:00:11
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Plant Health Care Plc LSE:PHC London Ordinary Share GB00B01JC540 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 3.73 3.64 3.98 - 101,405 08:00:11
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pesticides, Agric Chems, Nec 11.77M -9.48M -0.0278 -1.34 12.74M
Plant Health Care Plc is listed in the Pesticides, Agric Chems sector of the London Stock Exchange with ticker PHC. The last closing price for Plant Health Care was 3.73p. Over the last year, Plant Health Care shares have traded in a share price range of 3.20p to 12.00p.

Plant Health Care currently has 341,532,952 shares in issue. The market capitalisation of Plant Health Care is £12.74 million. Plant Health Care has a price to earnings ratio (PE ratio) of -1.34.

Plant Health Care Share Discussion Threads

Showing 901 to 925 of 1350 messages
Chat Pages: Latest  42  41  40  39  38  37  36  35  34  33  32  31  Older
DateSubjectAuthorDiscuss
14/3/2022
14:39
The real question is "Why is RG selling even at these low prices" Does he know something bad or does he just need cash or has he siscovered a better growth prospect?
pugugly
14/3/2022
14:26
Yes ridderone the continued increase in soybean prices is beneficial to PHC as can be seen that the price has not cratered with the rest of the small/micro cap market and also Friday's announcement that RG is continuing to sell down.
cerrito
24/2/2022
09:03
Soy Bean prices surging to near all time high has to be a big plus for PHC
riddlerone
11/2/2022
14:26
RG not done ?
oapknob1
09/2/2022
18:06
Two trades 7,000,000 and 6,000,000 about 4.3% of shares in issue.TR1 would be nice if they are buys and if bought by same buyer
oapknob1
09/2/2022
17:45
Massive volume today with a large buy after hours.Mmm nice.
geraldus
09/2/2022
15:51
As long as it's not on the cheap
oapknob1
09/2/2022
15:37
Well, somebody is buying. I thought there was a bit of a hint in the presentation that PHC could be a takeover target, and if the technology is now proved, it would make sense for somebody with 'a bit of cash' to take it over and drive the geographical and sector expansion faster than PHC can.
ewanwhose
07/2/2022
14:13
Directors buying would be nice
oapknob1
03/2/2022
13:14
RG now down to 15pc from 25pc last year. I guess we have to brace ourselves for a low price till he is out of for no other reason than people will be shy of buying if they think he will continue to sell.
I am perhaps more philosophical than I should be because when he exited Ceres the price appreciated smartly.

cerrito
01/2/2022
23:04
Best sell up then
oapknob1
01/2/2022
21:30
If products and prospects so fantastic WHY is share price down ovr 50% from year high?
pugugly
01/2/2022
20:04
Yes,another good presentation.First class on investor communications.
geraldus
01/2/2022
16:50
great presentations. beaming confidence. stock worth multiples (taking future into the account) .....
kaos3
01/2/2022
16:13
Targeting $30million revenue by 2025.
oapknob1
01/2/2022
14:04
New Cenkos note out.
ewanwhose
01/2/2022
11:36
I see that 2021 revenues were 12% up from Arden's estimate and 8% up from that of Cenkos but the market has yawned.
cerrito
01/2/2022
08:08
Dig for victory.Webcast later today.
geraldus
01/2/2022
07:09
01 February 2022Plant Health Care plc"Plant Health Care" or the "Company"Trading StatementPositioned as a leader in sustainable agricultureFebruary 1(st) , 2022 - Plant Health Care(R) (AIM.PHC.L), a leading provider of novel patent-protected biological products to global agriculture markets, announces its trading update for the 12-month period to 31(st) December. All results provided are preliminary and subject to completion of the 2021 audit.Financial and Commercial highlights: - Revenue increased 28% to $8.4m (2020: $6.6m)
oapknob1
01/2/2022
07:05
The Board remains confident that the Company is on track to deliver cash breakeven within existing financial resources.Chris Richards, CEO of Plant Health Care, said:"The Commercial business is now profitable and cash generative and set to deliver profitable growth over the coming years. Strong Harpin revenue growth, combined with the first of many product launches from the PREtec platform, mark a very strong year for Plant Health Care. The Company is now well positioned to become a leader in Sustainable Agriculture, as recognised by the award of the LSE's Green Economy Mark."Plant Health Care has established core relationships with four of the largest global agricultural distributors, giving us scale in key markets. Harpin sales growth of 55% was driven by substantial increases in all Regions. In Mexico, sales of Harpin increased by 15% but third-party product sales were held back due to low crop production in H1 2021."The launch of Saori into Brazil the world's largest soybean market has been well received. Sales volumes in 2021 were limited by the availability of product; however, the recently announced toll manufacturing agreement secures ample capacity to supply long-term growth in PHC279 (the active ingredient in Saori) at attractive cost for all global sales. Nutrien, our partner in Brazil, is excited about the potential for ramping up sales of Saori in 2022 and beyond."We plan multiple launches of PREtec products into other large markets over the coming years, following an investment of more than $25m over the last eight years. The next launch will be PHC279 for the specialty crop market in the USA, in partnership with Wilbur Ellis, in the second half of this year. The submission of the regulatory filing for PHC949 to the EPA in the USA sets the way for the first launch of that exciting product in 2023. Plans are in place for further major product launches in following years, as we build a large business from the PREtec platform."We have good visibility to future revenue growth expectations from our distributors and are confident that the momentum within the business will continue into 2022 and beyond. We remain on track to deliver cash breakeven within existing resources."
oapknob1
31/1/2022
10:47
Does look a tad ambitious but who knows.
geraldus
31/1/2022
10:03
I see we had a flurry of activity on Jan 18/19 with 2m of reported trades over the 2 days ie 2/3rds of 1% of shares outstanding but we have gone back to sleep with only 33 shares reportedly traded in the 3 days Tuesday to Thursday last week.
I also checked that there were no reported short positions-I would have been flabbergasted if there had been any.
Joint broker Cenkos has a note out today with a 25p tp. FWIW- and with great respect to Cenkos a lot of this is inspired guess work- they have an adjusted PBT of £3.2m next year ie 2023 and cash/equivalents of £8.2m at 31.12.23. If Cenkos are right the jam is quite close.
I note from my notes on the July 26 IMC call that they were then talking about submitting this application in Q4 21.

cerrito
31/1/2022
08:32
Next week there's more Field Day with Saori® !Catch up with more moments from the 7th Field Day with Saori®, now at Gaia Farm @algarfarmingoficial, em Monte Alegre de Minas (MG) com @matheusdpsWe are grateful for the presence of everyone and the hospitality of André Luis dos Santos Ribeiro, responsible director, of the group @algarfarmingoficial .Saori® is part of @nutrienbr's integrated solution that offers the farmer greater productivity, working with tranquility and profitability.On Field Day with Saori® you'll check out a visibly more sapling and ready to deliver the best results in saori 2021/22.
oapknob1
31/1/2022
08:24
Morning Pug...I am sure RG has not been happy with the performance,all began to unravel when the touted auctions were a bust.I have always thought IP value is there but at what price would the major shareholders be prepared to let it go for.Trading update tomorrow which should be positive but revenue needs to surprise the market for any meaningful recovery.
riddlerone
31/1/2022
07:45
Msrket cap £28M - "PHC949 to reach into the tens of millions of dollars over the long-term" We are all dead in the long term. Coupled with the rate of inflation we may never see any real value before being snapped up by a scalper for peanuts.

Also being hard hit by the massive sell off in maybe jam tomorrow stocks.

I hope I am wrong but one of the worst performers in AIM.

$64K question - Salvage what you can or dig in for possible recovery.

Very much (imo) depends on whether regulatory approval obtained -" after regulatory approval in 2023. " So potentially could be nearly 2 years before approval or rejection. Odds anyone?

pugugly
Chat Pages: Latest  42  41  40  39  38  37  36  35  34  33  32  31  Older

Your Recent History

Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: +44 (0) 203 8794 460 | support@advfn.com